The immune suppressive myeloma microenvironment has elevated IL-10 and TGF-beta, and was associated with decreased expression of NK activating receptors, TNF and IFN-γ secretion, and impaired NK cytotoxicity toward myeloma (1, 42, 43). This evidence concerns the gene SLAMF6 and plasma cell myeloma.